| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | TRIANGLE BIOTECHNOLOGY, INC | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43IP001232 | SBIR PA22-176 - Culture-free microbial enrichment for diagnosis and characterization of anti-microbial resistance | 01 | 1 | CDC | 10/25/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $997,367 ) |
| | 2024 | 2024 | TRIANGLE BIOTECHNOLOGY, INC | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R44AI152796 | Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | 000 | 4 | NIH | 4/30/2024 | $997,367 |
| | 2024 | 2021 | TRIANGLE BIOTECHNOLOGY, INC | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R44CA232902 | Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | 000 | 3 | NIH | 2/12/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,637,664 ) |
| | 2023 | 2023 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43IP001232 | SBIR PA22-176 - Culture-free microbial enrichment for diagnosis and characterization of anti-microbial resistance | 00 | 1 | CDC | 8/31/2023 | $300,000 |
| | 2023 | 2023 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43GM150348 | Development of nanodroplet enhanced ultrasonic cavitation technologyto enable the study of chromatin accessibility in FFPE tissues | 000 | 1 | NIH | 8/3/2023 | $339,300 |
| | 2023 | 2023 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R44AI152796 | Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | 000 | 3 | NIH | 4/6/2023 | $998,364 |
|
| Issue Date FY: 2022 ( Subtotal = $1,000,000 ) |
| | 2022 | 2022 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R44AI152796 | Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | 000 | 2 | NIH | 5/25/2022 | $1,000,000 |
| | 2022 | 2020 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43AI152796 | Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | 001 | 1 | NIH | 8/16/2022 | $0 |
| | 2022 | 2020 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43AI152796 | Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | 000 | 1 | NIH | 5/25/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,154,747 ) |
| | 2021 | 2021 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R44CA232902 | Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | 000 | 3 | NIH | 7/30/2021 | $1,154,747 |
| | 2021 | 2019 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43CA236177 | SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples | 000 | 1 | NIH | 8/12/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,096,788 ) |
| | 2020 | 2020 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43AI152796 | Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | 000 | 1 | NIH | 8/3/2020 | $252,131 |
| | 2020 | 2020 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R44CA232902 | Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | 000 | 2 | NIH | 9/9/2020 | $844,657 |
| | 2020 | 2018 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43CA232902 | Towards commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | 000 | 1 | NIH | 4/21/2020 | $0 |
| | 2020 | 2018 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43CA232902 | Towards commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | 001 | 1 | NIH | 5/2/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $298,529 ) |
| | 2019 | 2019 | TRIANGLE BIOTECHNOLOGY, INC. | 303 W BARBEE CHAPEL RD | CHAPEL HILL | NC | 27517-7513 | ORANGE | USA | R43CA236177 | SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples | 000 | 1 | NIH | 4/9/2019 | $298,529 |
|
| Issue Date FY: 2018 ( Subtotal = $298,530 ) |
| | 2018 | 2018 | TRIANGLE BIOTECHNOLOGY, INC. | 316 WHITNEY LN | DURHAM | NC | 27713-6651 | DURHAM | USA | R43CA232902 | Towards commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | 000 | 1 | NIH | 7/5/2018 | $298,530 |
|
|
